Basal-luminal Subtyping of Localized High-Risk Prostate Cancer and Benefit of Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase III Trial
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined